american heart association glp 1 GLP-1 receptor agonists as promising anti-inflammatory agents in failure with preserved ejection fraction The Cardiovascular Physiology of Glucagon-like

Context is everything

Its primary endpoint, cerebral glucose metabolism, was negative (difference -0.17, P = 0.14)

How to Use: Twice daily after cleansing, apply to skin with a cotton ball or pad

European Journal of Preventive Cardiology

Glucagon-like peptide-1 (GLP-1) receptor agonists represent a newer class of antidiabetic medications originally approved for type 2 diabetes management

The structural modification substituting a hydroxyl group where MT-II carries an amide was designed during Palatin Technologies' development program to concentrate therapeutic effects at MC3R and MC4R while stripping out the tanning and dermatological risk that come with strong MC1R agonism